National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)
Agency
National Institutes of Health
Posted
Oct 20, 2026
Due Date
Nov 1, 2027
Description
<p><span style="background-color:white;">The objective of this Notice of Funding Opportunity (NOFO) is to continue to support laboratories that constitute a collaborative network, the NIDCD National Human Ear Resource Network, to serve as a national technological resource for auditory and vestibular researchers to use human inner and middle ear tissues for a range of basic and clinical studies to advance knowledge and treatment of auditory and vestibular disorders. </span></p>
AI Summary
Estimated Funding: 3,600,000 | Award Ceiling: 450,000 | Agency: National Institutes of Health
Details
- Notice ID
- 361207
- Solicitation Number
- RFA-DC-28-001
- Classification Code
- D
Want to track opportunities like this?
Sign up for Kontratar to get AI-powered opportunity matching, ranking, and alerts.
Get Started FreeRelated opportunities
- Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed)
National Institutes of Health
- Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)
National Institutes of Health
- Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)
National Institutes of Health
- Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
- Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
- George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)
National Institutes of Health